Literature DB >> 26225200

Prognostic impact of atrial fibrillation on clinical outcomes of acute coronary syndromes, heart failure and chronic kidney disease.

Nileshkumar J Patel1, Aashay Patel1, Kanishk Agnihotri1, Dhaval Pau1, Samir Patel1, Badal Thakkar1, Nikhil Nalluri1, Deepak Asti1, Ritesh Kanotra1, Sabeeda Kadavath1, Shilpkumar Arora1, Nilay Patel1, Achint Patel1, Azfar Sheikh1, Neil Patel1, Apurva O Badheka1, Abhishek Deshmukh1, Hakan Paydak1, Juan Viles-Gonzalez1.   

Abstract

Atrial fibrillation (AF) is the most common type of sustained arrhythmia, which is now on course to reach epidemic proportions in the elderly population. AF is a commonly encountered comorbidity in patients with cardiac and major non-cardiac diseases. Morbidity and mortality associated with AF makes it a major healthcare burden. The objective of our article is to determine the prognostic impact of AF on acute coronary syndromes, heart failure and chronic kidney disease. Multiple studies have been conducted to determine if AF has an independent role in the overall mortality of such patients. Our review suggests that AF has an independent adverse prognostic impact on the clinical outcomes of acute coronary syndromes, heart failure and chronic kidney disease.

Entities:  

Keywords:  Acute coronary syndromes; Atrial fibrillation; Chronic kidney disease; Heart failure; Prognostic impact

Year:  2015        PMID： 26225200      PMCID： PMC4513491          DOI： 10.4330/wjc.v7.i7.397

Source DB:  PubMed          Journal:  World J Cardiol


  64 in total

1.  Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes.

Authors:  S S Rathore; A K Berger; K P Weinfurt; K A Schulman; W J Oetgen; B J Gersh; A J Solomon
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

2.  Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation.

Authors:  D M Clark; V J Plumb; A E Epstein; G N Kay
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

3.  Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction.

Authors:  Milika Asanin; Jovan Perunicic; Igor Mrdovic; Mihailo Matic; Bosiljka Vujisic-Tesic; Aleksandra Arandjelovic; Zorana Vasiljevic; Miodrag Ostojic
Journal:  Eur J Heart Fail       Date:  2005-06       Impact factor: 15.534

4.  Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in non-ischaemic dilated cardiomyopathy.

Authors:  S L D'Ascia; C D'Ascia; V Marino; A Lombardi; R Santulli; M Chiariello; G Santulli
Journal:  Int J Clin Pract       Date:  2011-11       Impact factor: 2.503

5.  Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.

Authors:  Keiko Nakagawa; Tadakazu Hirai; Shutaro Takashima; Nobuyuki Fukuda; Kazumasa Ohara; Etsuko Sasahara; Yoshiharu Taguchi; Nobuhiro Dougu; Takashi Nozawa; Kortaro Tanaka; Hiroshi Inoue
Journal:  Am J Cardiol       Date:  2011-01-19       Impact factor: 2.778

6.  Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume.

Authors:  Apurva O Badheka; Ankit Chothani; Kathan Mehta; Nileshkumar J Patel; Abhishek Deshmukh; Michael Hoosien; Neeraj Shah; Vikas Singh; Peeyush Grover; Ghanshyambhai T Savani; Sidakpal S Panaich; Ankit Rathod; Nilay Patel; Shilpkumar Arora; Vipulkumar Bhalara; James O Coffey; William O'Neill; Raj Makkar; Cindy L Grines; Theodore Schreiber; Luigi Di Biase; Andrea Natale; Juan F Viles-Gonzalez
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-12-05

7.  Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation.

Authors:  Stavroula N Psychari; Thomas S Apostolou; Loukas Sinos; Eftihia Hamodraka; George Liakos; Dimitrios Th Kremastinos
Journal:  Am J Cardiol       Date:  2005-03-15       Impact factor: 2.778

8.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

9.  Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.

Authors:  Simonetta Genovesi; Antonio Vincenti; Emanuela Rossi; Daniela Pogliani; Irene Acquistapace; Andrea Stella; Maria Grazia Valsecchi
Journal:  Am J Kidney Dis       Date:  2008-02       Impact factor: 8.860

10.  Clinical profile and outcomes of atrial fibrillation in elderly patients with acute myocardial infarction.

Authors:  Kang Li; Yong Huo; Yan-sheng Ding
Journal:  Chin Med J (Engl)       Date:  2008-12-05       Impact factor: 2.628
View more
  6 in total

1.  Left atrial deformation as a potent predictor for paroxysmal atrial fibrillation in patients with end-stage renal disease.

Authors:  Christodoulos E Papadopoulos; Efstathios Pagourelias; Constantinos Bakogiannis; Konstantinos Triantafyllou; Konstantinos Baltoumas; Efstratios Kassimatis; Dimitrios Zioutas; Dimitrios Siskos; Stergios Tzikas; Nikolaos Fragakis; Aikaterini Papagianni; Vassilios Vassilikos
Journal:  Int J Cardiovasc Imaging       Date:  2018-04-21       Impact factor: 2.357

2.  Fibroblast growth factor-21 is positively associated with atrial fibrosis in atrial fibrillation patients with rheumatic heart disease.

Authors:  Rui Wang; Xin Yi; Xiaoyan Li; Xuejun Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 3.  Evaluating the benefits of home-based management of atrial fibrillation: current perspectives.

Authors:  Azfar B Sheikh; Jamie R Felzer; Abdullah Bin Munir; Daniel P Morin; Carl J Lavie
Journal:  Pragmat Obs Res       Date:  2016-10-13

4.  Associations Between Neutrophil Gelatinase Associated Lipocalin, Neutrophil-to-Lymphocyte Ratio, Atrial Fibrillation and Renal Dysfunction in Chronic Heart Failure.

Authors:  Onur Argan; Dilek Ural; Guliz Kozdag; Tayfun Sahin; Serdar Bozyel; Mujdat Aktas; Kurtulus Karauzum; Irem Yilmaz; Emir Dervis; Aysen Agir
Journal:  Med Sci Monit       Date:  2016-12-05

5.  Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study.

Authors:  Maurizio Sessa; Annamaria Mascolo; Mikkel Porsborg Andersen; Giuseppe Rosano; Francesco Rossi; Annalisa Capuano; Christian Torp-Pedersen
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

Review 6.  Efficacy of Suxiao Jiuxin Pill on Coronary Heart Disease: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Li Ren; Jie Wang; Ling Feng; Shuli Wang; Jun Li
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-27       Impact factor: 2.629
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.